Apollomics Stock (NASDAQ: APLM) stock price, news, charts, stock research, profile.
Open | $0.20 |
Close | $0.21 |
Volume / Avg. | 1.18M / 1.02M |
Day Range | 0.20 - 0.23 |
52 Wk Range | 0.18 - 5.80 |
Market Cap | $21.95M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 0.19% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Apollomics (NASDAQ:APLM) through any online brokerage.
Other companies in Apollomics’s space includes: Vincerx Pharma (NASDAQ:VINC), Can Fite Biofarma (AMEX:CANF), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT) and Palatin Techs (AMEX:PTN).
There is no analysis for Apollomics.
Apollomics has a consensus price target of $8.50.
The stock price for Apollomics (NASDAQ: APLM) is $0.2 last updated July 23, 2024 at 7:45 PM EDT.
There are no upcoming dividends for Apollomics.
Apollomics’s H1 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Apollomics.
Apollomics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.